Skip to content
Home/Companies/Biotech/Bright Peak Therapeutics
Bright Peak Therapeutics

Bright Peak Therapeutics

Biotech·Switzerland·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Bright Peak Therapeutics?

Bright Peak Therapeutics is currently owned by TVM Capital Life Science through TVM Life Science Ventures (2004 vintage), since 2020.

Hand-verified · updated 2026-08-11

TVM Capital Life Science
Investor
TVM Capital Life Science
TVM Life Science Ventures · 2004 · VC

Key facts

HQSwitzerland
SectorBiotech
StatusActive
Websitebrightpeaktx.com

More from TVM Life Science Ventures

Other portfolio companies in the same fund.

CSA Medical, Inc.
Active
MedTechUnited States· 2024
Jacobian GmbH
Jacobian GmbH
Active
HealthTechGermany· 2024
Myosotis GmbH
Active
HealthTechGermany· 2024
Vektor Medical, Inc.
Active
MedTechUnited States· 2024
Zevra Therapeutics
Zevra Therapeutics
Active
PharmaUnited States· 2023
Egg Medical
Egg Medical
Active
MedTechUnited States· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Bright Peak Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Bright Peak Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue